Your browser doesn't support javascript.
loading
Endogenous TCR promotes in vivo persistence of CD19-CAR-T cells compared to a CRISPR/Cas9-mediated TCR knockout CAR.
Stenger, Dana; Stief, Tanja A; Kaeuferle, Theresa; Willier, Semjon; Rataj, Felicitas; Schober, Kilian; Vick, Binje; Lotfi, Ramin; Wagner, Beate; Grünewald, Thomas G P; Kobold, Sebastian; Busch, Dirk H; Jeremias, Irmela; Blaeschke, Franziska; Feuchtinger, Tobias.
Afiliação
  • Stenger D; Department of Pediatric Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Dr. von Hauner Children's Hospital, University Hospital, Ludwig Maximilians University Munich, Munich, Germany.
  • Stief TA; German Cancer Consortium, partner site, Munich, Germany.
  • Kaeuferle T; Department of Pediatric Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Dr. von Hauner Children's Hospital, University Hospital, Ludwig Maximilians University Munich, Munich, Germany.
  • Willier S; National Center for Infection Research, Munich, Germany.
  • Rataj F; Department of Pediatric Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Dr. von Hauner Children's Hospital, University Hospital, Ludwig Maximilians University Munich, Munich, Germany.
  • Schober K; Department of Pediatric Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Dr. von Hauner Children's Hospital, University Hospital, Ludwig Maximilians University Munich, Munich, Germany.
  • Vick B; Center for Integrated Protein Science Munich and Division of Clinical Pharmacology, Department of Medicine IV, Klinikum der Ludwig-Maximilians-Universität München, Munich, Germany.
  • Lotfi R; National Center for Infection Research, Munich, Germany.
  • Wagner B; Institute for Medical Microbiology, Immunology and Hygiene, Technische Universität München, Munich, Germany.
  • Grünewald TGP; Department of Pediatric Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Dr. von Hauner Children's Hospital, University Hospital, Ludwig Maximilians University Munich, Munich, Germany.
  • Kobold S; German Cancer Consortium, partner site, Munich, Germany.
  • Busch DH; Research Unit Apoptosis in Hematopoietic Stem Cells, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich, Germany.
  • Jeremias I; Institute for Transfusion Medicine, University Hospital Ulm, Ulm, Germany.
  • Blaeschke F; German Red Cross Blood Services Baden-Württemberg-Hessen, Institute for Clinical Transfusion Medicine and Immunogenetics Ulm, Ulm, Germany.
  • Feuchtinger T; Department for Transfusion Medicine, Cell Therapeutics and Hemostaseology, Klinikum der Ludwig-Maximilians-Universität München, Munich, Germany.
Blood ; 136(12): 1407-1418, 2020 09 17.
Article em En | MEDLINE | ID: mdl-32483603
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Receptores de Antígenos de Linfócitos T / Imunoterapia Adotiva / Leucemia-Linfoma Linfoblástico de Células Precursoras / Sistemas CRISPR-Cas Limite: Animals / Humans Idioma: En Revista: Blood Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Receptores de Antígenos de Linfócitos T / Imunoterapia Adotiva / Leucemia-Linfoma Linfoblástico de Células Precursoras / Sistemas CRISPR-Cas Limite: Animals / Humans Idioma: En Revista: Blood Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha